Peanut
Affordable legume nut linked to lower CVD and total mortality
Nutrition per serving 1 oz (28 g, ~28 peanuts)
- Sugars 1.3 g5%
- Fibre 2.4 g9%
- Other carbs 0.9 g3%
- Protein 7.3 g26%
- Fat 14 g50%
- Other 2.1 g8%
| Nutrient | Per serving | % daily value |
|---|---|---|
| Fiber | 2.4 g | 9% |
| Protein | 7.3 g | 15% |
| Vitamin E | 2.4 mg | 16% |
| Magnesium | 48 mg | 11% |
| Copper | 0.32 mg | 36% |
| Manganese | 0.55 mg | 24% |
| Zinc | 0.93 mg | 8% |
| Selenium | 2 µg | 4% |
| Phosphorus | 107 mg | 9% |
| Potassium | 200 mg | 4% |
| Iron | 1.3 mg | 7% |
| Calcium | 26 mg | 2% |
| Folate | 68 µg | 17% |
Composition data: USDA FoodData Central ↗
What is Peanut?
Peanut (Arachis hypogaea) is a nut or seed used for higher intake associated with lower cardiovascular and all-cause mortality in large cohorts. NutriDex grades the human evidence as Moderate. Peanuts are botanically a legume but nutritionally behave like tree nuts, supplying unsaturated fat, plant protein, fiber and L-arginine. The strongest human data are observational: in a prospective study of over 200,000 people across the US Southern Community Cohort and the Shanghai cohorts (Luu 2015), higher peanut/nut intake was associated with roughly 17-21% lower total mortality, driven mainly by fewer cardiovascular deaths. A systematic review and meta-analysis of randomized trials (2019) found peanut intake produced modest reductions in total cholesterol, triglycerides and diastolic blood pressure, though effects on LDL cholesterol were inconsistent and often non-significant. Randomized evidence specific to peanuts on hard endpoints is limited; the landmark PREDIMED trial (Estruch 2018) used mixed nuts (mostly walnuts, with almonds and hazelnuts) rather than peanuts, so its ~28% reduction in major cardiovascular events is not peanut-specific. Overall the evidence is moderate and largely consistent with the broader nut literature, but causal proof for peanuts alone is weaker than for walnuts or almonds.